• There are no suggestions because the search field is empty.

Careers    Developers    Support     日本語

Back to Resource Hub White paper

Measuring Cognitive Changes in Alzheimer's Patients Using CDR System: A Summary

Signant Health
Jun 11, 2024
White paper
White Paper Read Now

Discover the CDR System, a trusted and highly effective cognitive assessment tool that has been shaping international clinical trials for over 35 years and features an extensive comparative database.  

Explore how it has been applied in clinical trials to identify progressive impairment in healthy volunteers as well as patients with mild cognitive impairment (MCI) and Alzheimer's disease (AD). 

READ WHITE PAPER

Similar posts

Article

Age Matters in Alzheimer's Clinical Trials

See how age of onset impacts Alzheimer's disease treatment, including deep brain stimulation therapy response and crucial implications for trial...

Signant Health Jun 16, 2021

Looking for more insights? Explore related resources.

BROCHURE

Alzheimer's Dementia Research Solutions

SEE THE BROCHURE
ARTICLE

Effect of Age on Clinical Trial Outcome in Participants with Probable Alzheimer's Disease

READ THE ARTICLE
SOLUTION

Alzheimer's Disease Clinical Trial Solutions

VISIT THE PAGE

Get notified on new marketing insights

Here mention the benefits of subscribing